Targeting the RAS pathway by mitogen-activated protein kinase inhibitors

被引：13

作者：

Kiessling, Michael K. ^{[1
]}

Rogler, Gerhard ^{[1
]}

机构：

[1] Univ Zurich Hosp, Dept Gastroenterol & Hepatol, Raemistr 100, CH-8091 Zurich, Switzerland

来源：

SWISS MEDICAL WEEKLY | 2015年 / 145卷

关键词：

NRAS mutations; HRAS mutations; MEK inhibitor; ORAL MEK INHIBITOR; SMALL-CELL LUNG; BRAF-MUTANT MELANOMA; PHASE-II; OPEN-LABEL; AZD6244; ARRY-142886; METASTATIC MELANOMA; COMBINATION THERAPY; TUMOR PROGRESSION; DOSE-ESCALATION;

D O I：

10.4414/smw.2015.14207

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Targeting of oncogenic driver mutations with small-molecule inhibitors resulted in powerful treatment options for cancer patients in recent years. The RAS (rat sarcoma) pathway is among the most frequently mutated pathways in human cancer. Whereas targeting mutant Kirsten RAS (KRAS) remains difficult, mutant B rapidly accelerated fibrosarcoma (BRAF) kinase is an established drug target in cancer. Now data show that neuroblastoma RAS (NRAS) and even Harvey RAS (HRAS) mutations could be predictive markers for treatment with mitogen-activated protein kinase (MEK) inhibitors. This review discusses recent preclinical and clinical studies of MEK inhibitors in BRAF and RAS mutant cancer.

引用

页数：9

共 50 条

[41] Low-concentration vemurafenib induces the proliferation and invasion of human HaCaT keratinocytes through mitogen-activated protein kinase pathway activation [J].

Roh, Mi Ryung ;

Kim, Jung Min ;

Lee, Sang Hee ;

Jang, Hong Sun ;

Park, Kyu Hyun ;

Chung, Kee Yang ;

Rha, Sun Young .

JOURNAL OF DERMATOLOGY, 2015, 42 (09) :881-888

[42] Novel protein kinase C isoforms and mitogen-activated kinase kinase mediate phorbol ester-induced osteopontin expression [J].

Chang, PL ;

Tucker, MA ;

Hicks, PH ;

Prince, CW .

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (09) :1142-1151

[43] Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering [J].

Susumu Tanimura ;

Yuji Chatani ;

Rika Hoshino ;

Masahiro Sato ;

Shin-ichi Watanabe ;

Tadashi Kataoka ;

Toshikazu Nakamura ;

Michiaki Kohno .

Oncogene, 1998, 17 :57-65

[44] Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering [J].

Tanimura, S ;

Chatani, Y ;

Hoshino, R ;

Sato, M ;

Watanabe, S ;

Kataoka, T ;

Nakamura, T ;

Kohno, M .

ONCOGENE, 1998, 17 (01) :57-65

[45] Suppression of the SLC7A11/glutathione axis causes ferroptosis and apoptosis and alters the mitogen-activated protein kinase pathway in nasopharyngeal carcinoma [J].

Wang, Hai-Hua ;

Fan, Song-Qing ;

Zhan, Yu-Ting ;

Peng, Shu-Ping ;

Wang, Wei-Yuan .

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 254

[46] Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases [J].

Zila, Nina ;

Bileck, Andrea ;

Muqaku, Besnik ;

Janker, Lukas ;

Eichhoff, Ossia M. ;

Cheng, Phil F. ;

Dummer, Reinhard ;

Levesque, Mitchell P. ;

Gerner, Christopher ;

Paulitschke, Verena .

CLINICAL PROTEOMICS, 2018, 15

[47] Prp19 facilitates invasion of hepatocellular carcinoma via p38 mitogen-activated protein kinase/twist1 pathway [J].

Yin, Jie ;

Wang, Lan ;

Zhu, Ji-Min ;

Yu, Qian ;

Xue, Ru-Yi ;

Fang, Ying ;

Zhang, Yi-An ;

Chen, Yan-Jie ;

Liu, Tao-Tao ;

Dong, Ling ;

Shen, Xi-Zhong .

ONCOTARGET, 2016, 7 (16) :21939-21951

[48] A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours [J].

Jamieson, David ;

Griffin, Melanie J. ;

Sludden, Julieann ;

Drew, Yvette ;

Cresti, Nicola ;

Swales, Karen ;

Merriman, Mark ;

Allen, Rodger ;

Bevan, Paul ;

Buerkle, Markus ;

Mala, Carola ;

Coyle, Vicky ;

Rodgers, Lisa ;

Dean, Emma ;

Greystoke, Alastair ;

Banerji, Udai ;

Wilson, Richard H. ;

Evans, T. R. Jeffery ;

Anthoney, Alan ;

Ranson, Malcolm ;

Boddy, Alan V. ;

Plummer, Ruth .

EUROPEAN JOURNAL OF CANCER, 2016, 68 :1-10

[49] Mitogen-activated protein kinase signaling causes malignant melanoma cells to differentially alter extracellular matrix biosynthesis to promote cell survival [J].

Afasizheva, Anna ;

Devine, Alexus ;

Tillman, Heather ;

Fung, King Leung ;

Vieira, Wilfred D. ;

Blehm, Benjamin H. ;

Kotobuki, Yorihisa ;

Busby, Ben ;

Chen, Emily I. ;

Tanner, Kandice .

BMC CANCER, 2016, 16

[50] Studies of the mitogen-activated protein kinases and phosphatidylinositol-3 kinase in the lens. 2. The intercommunications [J].

Zatechka, DS ;

Lou, MF .

EXPERIMENTAL EYE RESEARCH, 2002, 75 (02) :177-192

← 1 2 3 4 5 →